{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:23:24Z","timestamp":1772249004397,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bpg.2012.01.009","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T03:57:45Z","timestamp":1335326265000},"page":"185-195","source":"Crossref","is-referenced-by-count":27,"title":["Aspirin and the prevention of colorectal cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"\u00c1ngel","family":"Ferr\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Piazuelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2012.01.009_bib1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2012.01.009_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.gastro.2009.06.015","article-title":"Concepts in familial colorectal cancer: where do we stand and what is the future?","volume":"137","author":"Castells","year":"2009","journal-title":"Gastroenterology"},{"issue":"788-96","key":"10.1016\/j.bpg.2012.01.009_bib3","article-title":"Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype","volume":"139","author":"Abuli","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.009_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ng.111","article-title":"A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3","volume":"40","author":"Tomlinson","year":"2008","journal-title":"Nat Genet"},{"issue":"Suppl 5","key":"10.1016\/j.bpg.2012.01.009_bib5","first-page":"v78","article-title":"Familial colorectal cancer risk: ESMO Clinical Practice Guidelines","volume":"21","author":"Balmana","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpg.2012.01.009_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5009\/gnl.2010.4.2.151","article-title":"Hereditary colon cancer: Lynch syndrome","volume":"4","author":"Jang","year":"2010","journal-title":"Gut Liver"},{"issue":"Spec No 2","key":"10.1016\/j.bpg.2012.01.009_bib7","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1093\/hmg\/ddh247","article-title":"An update on the genetics of colorectal cancer","volume":"13","author":"Kemp","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bpg.2012.01.009_bib8","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1001\/jama.293.16.1986","article-title":"Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer","volume":"293","author":"Pi\u00f1ol","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2012.01.009_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.surge.2011.01.011","article-title":"The molecular biology of colorectal carcinoma and its implications: a review","volume":"9","author":"Harrison","year":"2011","journal-title":"Surgeon"},{"key":"10.1016\/j.bpg.2012.01.009_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","article-title":"The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force","volume":"146","author":"Dub\u00e9","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib11","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2008.02.002","article-title":"Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on colorectal cancer, and the American College of Radiology","volume":"134","author":"Levin","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.009_bib12","series-title":"European guidelines for quality assurance in colorectal cancer screening and diagnosis","year":"2010"},{"key":"10.1016\/j.bpg.2012.01.009_bib13","first-page":"1332","article-title":"Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)","volume":"35","author":"Sporn","year":"1976","journal-title":"Fed Proc"},{"key":"10.1016\/j.bpg.2012.01.009_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib15","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.bpg.2012.01.009_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/14728220802653631","article-title":"Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?","volume":"13","author":"Doherty","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bpg.2012.01.009_bib17","first-page":"4705","article-title":"Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice","volume":"60","author":"Chulada","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2012.01.009_bib18","first-page":"4872","article-title":"Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis","volume":"63","author":"Takeda","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2012.01.009_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.plefa.2004.10.006","article-title":"Platelet activation in patients with colorectal cancer","volume":"72","author":"Sciulli","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.bpg.2012.01.009_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bpg.2012.01.009_bib21","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpg.2012.01.009_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/157489206778776961","article-title":"Regulation of cell proliferation and apoptosis by bioactive lipid mediators","volume":"1","author":"Cl\u00e0ria","year":"2006","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.bpg.2012.01.009_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/156652409788488748","article-title":"Role of lipoxins and resolvins as anti-inflammatory and Proresolving mediators in colon cancer","volume":"9","author":"Janakiram","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.00-0529fje","article-title":"Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells","volume":"15","author":"Stark","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.bpg.2012.01.009_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/carcin\/bgl220","article-title":"Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in\u00a0vivo models of human colorectal cancer","volume":"28","author":"Stark","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bpg.2012.01.009_bib26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bpg.2012.01.009_bib27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1179689","article-title":"Regulation of cellular metabolism by protein lysine acetylation","volume":"327","author":"Zhao","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bpg.2012.01.009_bib28","first-page":"597","article-title":"Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells","volume":"34","author":"Alfonso","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bpg.2012.01.009_bib29","first-page":"1273","article-title":"Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: identification of novel targets","author":"Marimuthu","year":"2011","journal-title":"Int J Oncolo"},{"key":"10.1016\/j.bpg.2012.01.009_bib30","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1078-0432.CCR-05-1581","article-title":"Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency","volume":"12","author":"Castells","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpg.2012.01.009_bib31","first-page":"383","article-title":"A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells","volume":"9","author":"Goel","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpg.2012.01.009_bib32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1940-6207.CAPR-10-0319","article-title":"Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model","volume":"4","author":"Mcilhatton","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bpg.2012.01.009_bib33","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","article-title":"Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome","volume":"359","author":"Burn","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1113\/jphysiol.2005.100586","article-title":"Cell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylate","volume":"571","author":"Nunez","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.bpg.2012.01.009_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2008.09.020","article-title":"Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity","volume":"77","author":"Spitz","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bpg.2012.01.009_bib36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1126\/science.291.5504.581","article-title":"Cancer research. Anti-inflammatories inhibit cancer growth\u2013but how?","volume":"291","author":"Marx","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bpg.2012.01.009_bib37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/carcin\/bgh118","article-title":"DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1","volume":"25","author":"Hardwick","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bpg.2012.01.009_bib38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.gastro.2008.02.012","article-title":"Chemoprevention of colorectal neoplasia: the potential for personalized medicine","volume":"134","author":"Arber","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.009_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(07)70139-0","article-title":"Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back","volume":"8","author":"Bertagnolli","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpg.2012.01.009_bib40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","article-title":"Aspirin and the risk of colorectal cancer in women","volume":"333","author":"Giovannucci","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib41","first-page":"4399","article-title":"Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study","volume":"48","author":"Kune","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2012.01.009_bib42","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2012.01.009_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-146-5-200703060-00008","article-title":"Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement","volume":"146","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1940-6207.CAPR-11-0106","article-title":"A randomized placebo-controlled prevention trial of aspirin and\/or resistant starch in young people with familial adenomatous polyposis","volume":"4","author":"Burn","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.bpg.2012.01.009_bib45","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2012.01.009_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.gastro.2007.10.014","article-title":"Aspirin and folic acid for the prevention of recurrent colorectal adenomas","volume":"134","author":"Logan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.009_bib47","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.297.21.2351","article-title":"Folic acid for the prevention of colorectal adenomas: a randomized clinical trial","volume":"297","author":"Cole","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2012.01.009_bib48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","article-title":"Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial","volume":"125","author":"Benamouzig","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.009_bib49","article-title":"Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial","author":"Benamouzig","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2012.01.009_bib50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib51","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.01.009_bib52","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica en prevenci\u00f3n del c\u00e1ncer colorrectal","author":"Castells","year":"2009","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2012.01.009_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14320","article-title":"Chemoprevention of colorectal cancer: systematic review and economic evaluation","volume":"14","author":"Cooper","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bpg.2012.01.009_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women\u2019s Health Study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2012.01.009_bib55","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jnci\/85.15.1220","article-title":"Low-dose aspirin and incidence of colorectal tumors in a randomized trial","volume":"85","author":"Gann","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2012.01.009_bib56","first-page":"313","volume":"vol. 296","author":"Peto","year":"1988"},{"key":"10.1016\/j.bpg.2012.01.009_bib57","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691812000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691812000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T22:10:50Z","timestamp":1561673450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691812000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1521691812000108"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2012.01.009","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}